Table of Contents Author Guidelines Submit a Manuscript
Advances in Urology
Volume 2009, Article ID 328364, 4 pages
http://dx.doi.org/10.1155/2009/328364
Clinical Study

Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder

Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA

Received 25 March 2009; Revised 22 June 2009; Accepted 29 July 2009

Academic Editor: Flavio Trigo Rocha

Copyright © 2009 Brian L. Cohen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Milsom, P. Abrams, L. Cardozo, R. G. Roberts, J. Thüroff, and A. J. Wein, “How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study,” BJU International, vol. 87, no. 9, pp. 760–766, 2001. View at Publisher · View at Google Scholar
  2. B. L. Cohen, H. S. G. Tunuguntla, and A. Gousse, “Predictors of success for first stage neuromodulation: motor versus sensory response,” Journal of Urology, vol. 175, no. 6, pp. 2178–2181, 2006. View at Publisher · View at Google Scholar · View at PubMed
  3. D. M. Schmid, P. Sauermann, M. Werner et al., “Experience With 100 cases treated with botulinum-a toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics,” Journal of Urology, vol. 176, no. 1, pp. 177–185, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. A. Sahai, M. S. Khan, N. Le Gall, and P. Dasgupta, “Urodynamic assessment of poor responders after botulinum toxin-a treatment for overactive bladder,” Urology, vol. 71, no. 3, pp. 455–459, 2008. View at Publisher · View at Google Scholar · View at PubMed
  5. E. Compérat, A. Reitz, A. Delcourt, F. Capron, P. Denys, and E. Chartier-Kastler, “Histologic features in the urinary bladder wall affected from neurogenic overactivity-a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A,” European Urology, vol. 50, no. 5, pp. 1058–1064, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. P. Abrams, L. Cardozo, M. Fall et al., “The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society,” Neurourology and Urodynamics, vol. 21, no. 2, pp. 167–178, 2002. View at Publisher · View at Google Scholar · View at PubMed
  7. J. G. Blaivas and A. Groutz, “Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology,” Neurourology and Urodynamics, vol. 19, no. 5, pp. 553–564, 2000. View at Publisher · View at Google Scholar
  8. B. L. Cohen, B. Rivera, P. G. Barboglio, and A. Gousse, “Safety, tolerability, and efficacy of sedation-free flexible cystoscopy for intra-detrusor botulinum toxin-a injection,” The Journal of Urology, vol. 177, no. 3, pp. 1006–1010, 2007. View at Google Scholar